It has been shown that the positivity rate of THSD7A in malignant tumors is 15%–20% (22), and the messenger RNA of THSD7A was detected in some tumor tissues (gallbladder cancer) and THSD7A protein was detected in dendritic cells of tumor-infiltrating lymph node germinal centers (23, 24). This evidence concerns the gene THSD7A and neoplasm.